|
Biomerica, Inc. (BMRA) DCF Valoración
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Biomerica, Inc. (BMRA) Bundle
¡Ahorre tiempo y mejore la precisión con nuestra calculadora DCF (BMRA)! Utilizando datos reales de Biomerica y supuestos personalizables, esta herramienta le permite pronosticar, analizar y valorar Biomerica, Inc. como un inversor experimentado.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.7 | 7.2 | 18.9 | 5.3 | 5.4 | 5.9 | 6.5 | 7.1 | 7.7 | 8.5 |
| Revenue Growth, % | 0 | 7.57 | 162.14 | -71.71 | 1.42 | 9.32 | 9.32 | 9.32 | 9.32 | 9.32 |
| EBITDA | -2.3 | -7.1 | -3.9 | -6.7 | -6.0 | -4.2 | -4.6 | -5.0 | -5.5 | -6.0 |
| EBITDA, % | -33.97 | -98.03 | -20.87 | -126.2 | -110.67 | -70.58 | -70.58 | -70.58 | -70.58 | -70.58 |
| Depreciation | .4 | .4 | .6 | .4 | .4 | .3 | .4 | .4 | .4 | .5 |
| Depreciation, % | 5.96 | 5.22 | 3.15 | 6.57 | 6.91 | 5.56 | 5.56 | 5.56 | 5.56 | 5.56 |
| EBIT | -2.7 | -7.4 | -4.5 | -7.1 | -6.4 | -4.3 | -4.7 | -5.1 | -5.6 | -6.2 |
| EBIT, % | -39.93 | -103.25 | -24.02 | -132.78 | -117.58 | -72.79 | -72.79 | -72.79 | -72.79 | -72.79 |
| Total Cash | 8.6 | 4.2 | 5.9 | 9.7 | 4.2 | 4.3 | 4.7 | 5.2 | 5.7 | 6.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.8 | 1.5 | .8 | .7 | .9 | 1.0 | 1.1 | 1.2 | 1.3 | 1.4 |
| Account Receivables, % | 26.38 | 20.21 | 4.1 | 13.52 | 17.49 | 16.34 | 16.34 | 16.34 | 16.34 | 16.34 |
| Inventories | 2.9 | 3.2 | 2.4 | 2.1 | 2.4 | 2.2 | 2.4 | 2.6 | 2.8 | 3.1 |
| Inventories, % | 42.6 | 44.53 | 12.8 | 38.51 | 43.88 | 36.46 | 36.46 | 36.46 | 36.46 | 36.46 |
| Accounts Payable | .8 | .4 | .7 | .3 | .3 | .4 | .4 | .5 | .5 | .6 |
| Accounts Payable, % | 12.45 | 5.99 | 3.9 | 6.44 | 5.32 | 6.82 | 6.82 | 6.82 | 6.82 | 6.82 |
| Capital Expenditure | -.1 | -.3 | -.2 | -.1 | -.1 | -.1 | -.1 | -.1 | -.2 | -.2 |
| Capital Expenditure, % | -1.78 | -4.11 | -0.90261 | -1.46 | -2.12 | -2.07 | -2.07 | -2.07 | -2.07 | -2.07 |
| Tax Rate, % | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 | -0.70755 |
| EBITAT | -2.7 | -7.4 | -4.6 | -7.1 | -6.4 | -4.3 | -4.7 | -5.1 | -5.6 | -6.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -6.2 | -7.8 | -2.4 | -6.8 | -6.8 | -3.8 | -4.7 | -5.2 | -5.7 | -6.2 |
| WACC, % | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 | 5.27 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -21.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -6 | |||||||||
| Terminal Value | -193 | |||||||||
| Present Terminal Value | -149 | |||||||||
| Enterprise Value | -171 | |||||||||
| Net Debt | -3 | |||||||||
| Equity Value | -168 | |||||||||
| Diluted Shares Outstanding, MM | 17 | |||||||||
| Equity Value Per Share | -9.96 |
What You Will Get
- Genuine Biomerica Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Biomerica, Inc. (BMRA).
- Comprehensive Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates to suit your analysis.
- Immediate Valuation Adjustments: Automatic recalculations to assess the effects of changes on Biomerica’s fair value.
- Flexible Excel Template: Designed for quick modifications, scenario testing, and thorough projections.
- Efficient and Precise: Avoid starting from scratch while ensuring accuracy and adaptability in your financial models.
Key Features
- Comprehensive DCF Model: Features detailed unlevered and levered DCF valuation frameworks tailored for Biomerica, Inc. (BMRA).
- WACC Analysis Tool: Ready-to-use Weighted Average Cost of Capital calculator with adjustable parameters.
- Customizable Forecast Inputs: Easily alter growth projections, capital investments, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency metrics specific to Biomerica, Inc. (BMRA).
- Interactive Dashboard and Visuals: Graphical representations highlight essential valuation indicators for straightforward interpretation.
How It Works
- 1. Access the Template: Download and open the Excel file featuring Biomerica, Inc.'s preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation outcomes.
- 5. Present with Assurance: Share professional valuation insights to bolster your decision-making.
Why Choose This Calculator for Biomerica, Inc. (BMRA)?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for Biomerica, Inc. (BMRA).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Biomerica’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable foundations for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Biomerica, Inc. (BMRA).
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Biomerica, Inc. (BMRA) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Biomerica, Inc. (BMRA).
- Consultants: Deliver professional valuation insights regarding Biomerica, Inc. (BMRA) to clients quickly and accurately.
- Business Owners: Understand how companies like Biomerica, Inc. (BMRA) are valued to guide your own strategic decisions.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Biomerica, Inc. (BMRA).
What the Template Contains
- Preloaded BMRA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.